All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
1 warning event since 2019; the latest 2020-11-25.
From the record
Viatris Inc.'s filings since 2019 show 1 warning event: an auditor change (8-K item 4.01, the latest 2020-11-25) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+3.2% a year over 8 filed years; profitable in 4 of 8.
From the record
Viatris Inc.'s 8 filed years say what it did: revenue went from $11 billion in fiscal 2018 to $14 billion in fiscal 2025, up 3.2% a year; it rose in 3 of 7 years; the deepest fall was 20% from fiscal 2021 to fiscal 2025; net income was positive in 4 of 8 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 4.9/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Viatris Inc.'s shareholder treatment is put at 4.9 of 10 with a confidence of 35 of 100, because read from one part only, the cash returned against operating cash flow, which ranks in the bottom 49% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -24%: lost 24¢ per shareholder dollar. Leverage 60%: owes 60¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-12-31, Viatris Inc. lost about 24 cents for every dollar of shareholders' money, and gross profitability: its products earned about 13 cents per dollar of everything the company owns. Leverage: it owed about 60 cents per dollar of assets (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
top 35% of 315 in its family; net margin -24.6%.
From the record
Viatris Inc.'s standing among 315 graded names in its industry family: revenue of $14 billion in fiscal 2025 ranks in the top 4% by size; a net margin of -24.6% ranks in the top 33%; revenue growth of -4.2% a year over the last 3 filed years ranks in the bottom 32% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
bottom 35% of 315 in its family for leadership; chief executive since 2023.
From the record
Viatris Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Smith, Scott Andrew (Chief Executive Officer, as filed), filing under that title since 2023-04-04, 3.6 years (bottom 38% of its family); the 18 officers and directors filing in the last fifteen months have been on the record a median of 3.7 years (bottom 21%); 9 officer or director changes were reported on Form 8-K since 2023-11-13, against the 18 people in charge now (bottom 45%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they set up to do next?
How much room does it have to grow?
bottom 28% of 273 in its family for room to expand.
From the record
Viatris Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $1.3 billion against debt of $12 billion leaves -29.9% of its assets as net cash, bottom 4% of its family; cash from operations less capital spending is 13.5% of revenue (top 19%); a gross margin of 35.1% (bottom 18%); research spending of 6.8% of revenue (bottom 8%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 50% of 306 in its family for growth drivers.
From the record
Viatris Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -4.2% a year over the last three filed years against 3.2% over all 8, slowing (bottom 40% of its family); the newest year grew -3% (bottom 33%); research spending grew 13.4% a year (top 33%); capital spending grew -2.3% a year (top 41%) (its annual reports). Viatris Inc. reported 15 product lines in fiscal 2025: Brands at $9.2 billion (64%), Lipitor at $1.5 billion (11%), Lyrica at $487 million (3%), and 12 more; 9 of 15 grew against the year before (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 29% of 233 in its family for expectations against reality.
From the record
Viatris Inc.'s newest year against its own record: revenue of $14 billion in fiscal 2025 came in 1.9% above the $14 billion its prior three years' pace pointed to (top 41% of its family); net income of $3.5 billion against a prior three-year average of $500 million (bottom 3%); a net margin of -24.6% against 2.9% before (bottom 24%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made